PTIX — Protagenic Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Annual balance sheet for Protagenic Therapeutics, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2022 December 31st	2023 December 31st	2024 December 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	8-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	7.98	4.06	1.84	0.015	1.51
Net Total Receivables	—	—	—	0.074	0
Total Inventory
Prepaid Expenses
Total Current Assets	8.04	4.2	1.88	0.089	1.54
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.123	0.073	—	0.015
Net Intangible Assets
Total Assets	8.04	4.32	1.96	0.089	3.65
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.12	0.655	0.943	5.04	1.03
Long Term Debt
Total Long Term Debt
Total Debt
Total Liabilities	1.12	0.655	0.943	5.04	1.03
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6.92	3.67	1.01	-4.95	2.62
Total Liabilities & Shareholders' Equity	8.04	4.32	1.96	0.089	3.65
Total Common Shares Outstanding
Total Preferred Shares Outstanding